Month:

Nasdaq: NSRX Delivering Rapid Relief When Every Second Counts Nasus Pharma Ltd. (NYSE American: NSRX) is a clinical-stage pharmaceutical company focused on the development of innovative intranasal products, utilizing its proprietary powder-based intranasal (PBI) platform to address acute medical conditions and public health threats. Chart Website LATEST NEWS Nasus Pharma Advances NS002 Towards Pivotal Study… Continue reading NSRX

Nasdaq: CNXU Architecting Bioregeneration Conexeu Sciences Inc. (Nasdaq: CNXU) is a medical device development company advancing a collagen-based extracellular matrix scaffold designed to support tissue regeneration across wound care, aesthetics, oral health, animal health, and 3D bioprinting. Chart Website Since the Patient The Hidden $11 Billion Economy Behind One of the Decade’s Most Explosive Headlines… Continue reading CNXU

Nasdaq: GRML Unlocking One of the World’s Largest Undeveloped PGM-Gold Deposits Greenland Mines Ltd. (Nasdaq: GRML) is a Nasdaq-listed company with two operating divisions: Natural Resources, focused on the exploration and development of the Skaergaard Project in Southeast Greenland, one of the largest undeveloped palladium, gold, and platinum deposits in the world; and Cell and… Continue reading GRML

Nasdaq: CUE Mobilizing the Patient’s Immune System to Treat Serious Diseases Cue Biopharma, Inc. (Nasdaq: CUE) is a clinical-stage biopharmaceutical company developing a novel class of engineered biologics to selectively modulate disease-specific T cells for the treatment of autoimmune, inflammatory, and oncological diseases. Chart Website LATEST NEWS CUE Biopharma Announces $30 Million Private Placement and… Continue reading CUE